Presentation is loading. Please wait.

Presentation is loading. Please wait.

Matthew D. Vesely, MD, PhD, Suguru Imaeda, MD, Brett A. King, MD, PhD 

Similar presentations


Presentation on theme: "Matthew D. Vesely, MD, PhD, Suguru Imaeda, MD, Brett A. King, MD, PhD "— Presentation transcript:

1 Tofacitinib citrate for the treatment of refractory, severe chronic actinic dermatitis 
Matthew D. Vesely, MD, PhD, Suguru Imaeda, MD, Brett A. King, MD, PhD  JAAD Case Reports  Volume 3, Issue 1, Pages 4-6 (January 2017) DOI: /j.jdcr Copyright © Terms and Conditions

2 Fig 1 CAD before and after treatment with tofacitinib. A and C, Before treatment with tofacitinib, there were edematous and lichenified pink-red and violaceous plaques photodistributed on the face, chest, and posterior neck, with sharp demarcation at the shirt collar. B and D, Marked improvement in the rash visible 10 months after starting tofacitinib (photographs taken during the spring). JAAD Case Reports 2017 3, 4-6DOI: ( /j.jdcr ) Copyright © Terms and Conditions


Download ppt "Matthew D. Vesely, MD, PhD, Suguru Imaeda, MD, Brett A. King, MD, PhD "

Similar presentations


Ads by Google